Amniotic membrane transplantation in children with symblepharon and massive pannus

Raina Goyal1, Sophie M Jones, Marcela Espinosa

  • 1Department of Ophthalmology and VCB Theatres, Great Ormond Street Hospital for Children, and Visual Sciences Unit, Institute of Child Health, London, England.

Insights

Amniotic membrane transplantation effectively reconstructs ocular surfaces in children with severe conditions like epidermolysis bullosa. This procedure improves vision and comfort, offering lasting results for ocular surface disease.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Pediatric Surgery

Background:

  • Severe ocular surface disease in children, including conditions like epidermolysis bullosa, often requires complex surgical interventions.
  • Forniceal and ocular surface reconstruction are critical for restoring function and preventing further visual impairment in pediatric patients.
  • Amniotic membrane transplantation (AMT) is a recognized therapeutic option for various ocular surface pathologies.

Observation:

  • A retrospective review of four pediatric patients (five eyes) undergoing AMT for ocular surface and forniceal reconstruction was conducted.
  • Diagnoses included epidermolysis bullosa, laryngo-onychocutaneous syndrome, and measles-related keratitis with HIV.
  • Patients experienced improved ocular comfort and anatomical restoration of ocular surfaces post-surgery.

Findings:

  • Mean visual acuity improved from 1.1 logMAR preoperatively to 0.7 logMAR postoperatively.
  • Three out of five eyes showed improved visual acuity.
  • Amniotic membrane transplantation demonstrated effectiveness in managing symblepharon and corneal scarring in pediatric cases, with better outcomes observed in patients with epidermolysis bullosa.

Implications:

  • Amniotic membrane transplantation is a viable and effective surgical strategy for pediatric ocular surface and forniceal reconstruction.
  • The procedure offers significant benefits in terms of visual acuity improvement and patient comfort for children suffering from severe ocular surface conditions.
  • Further research with larger cohorts is warranted to confirm long-term efficacy and compare outcomes across different pediatric ocular surface pathologies.
Abstract

Related Concept Videos